Verdes Management appoints Adam Reynolds to the Board as Non-Executive Director

– UK, London – Verdes Management plc (AIM: VMP) announces the following appointment to the Board. Adam Reynolds is joining the Board with immediate effect as a non-executive Director. 

Adam will work with the current board to implement and execute the Company’s new investing strategy which was approved by shareholders following its classification as an investing company earlier this year.

Adam is a former stockbroker who specialises in corporate finance. He has built, rescued and re-financed a number of public companies, notably EKF Diagnostics Plc, Orogen Gold Plc and more recently Premaitha Health PLC and Optibiotix Health PLC. Adam also led the take-private of Autoclenz Group Limited from AutoClenz Plc. 

David Mends has left the board with immediate effect.

Gill Leates, Chairman, commented: “I am delighted to welcome Adam to the Board. His wide-ranging business experience and city influence will serve the Company well as Verdes seeks to further implement its investing policy.”

 

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.